Not logged in.png)
Share.png)
SaveShare Save Share Save Share Save Conditional recurrence-free survival after curative esophagectomy: individual patient data analysis of 11 trials
Okui, Jun; Matsuda, Satoru; Nagashima, Kengo; Sato, Yasunori; Kawakubo, Hirofumi; Ruhstaller, Thomas; Thuss-Patience, Peter; Nilsson, Magnus; Klevebro, Fredrik; Tan, Lijie; Zhang, Shaoyuan; Aparicio, Thomas; Piessen, Guillaume; Van Der Zijden, Charlene; Mostert, Bianca; Wijnhoven, Bas P. L.; Tsushima, Takahiro; Takeuchi, Hiroya; Kato, Ken; Kitagawa, Yuko Share Save Share Save Share Save Share Save Share Save Computer-aided diagnosis system for predicting deeply invasive colorectal cancer: a comparison with a prospective study using magnifying chromoendoscopyMatsumura, Tomoaki; Fujie, Mai; Nomura, Yukihiro; Okimoto, Kenichiro; Tokunaga, Mamoru; Ishikawa, Tsubasa; Akizue, Naoki; Matsusaka, Keisuke; Suzuki, Takuto; Kitagawa, Yoshiyasu; Nagashima, Kengo; Nakaguchi, Toshiya; Kato, Jun Share Save Share Save Share Save Disease Complexity and Nodule-Specific Responses to Atezolizumab plus Bevacizumab in Advanced Hepatocellular CarcinomaYumita, Sae; Ogasawara, Sadahisa; Fujiya, Makoto; Akatsuka, Teppei; Izai, Ryo; Katayama, Keiichi; Sawada, Midori; Tsuchiya, Takahiro; Miwa, Chihiro; Yoshino, Ryohei; Yonemoto, Takuya; Kanzaki, Hiroaki; Koroki, Keisuke; Inoue, Masanori; Kobayashi, Kazufumi; Nakamura, Masato; Kanogawa, Naoya; Nakamoto, Shingo; Nagashima, Kengo; Kato, Jun Share Save Share Save Share Save A phase I/II trial evaluating the safety of increased-dose S-1 with oxaliplatin and nivolumab in HER2-negative advanced gastric cancerBaba, Keisuke; Suzuki, Nobumi; Imamura, Chiyo K.; Booka, Eisuke; Takeuchi, Masashi; Takahari, Daisuke; Kawakami, Takeshi; Kawakubo, Hirofumi; Kitagawa, Chiyoe; Kono, Yoshiyasu; Ogura, Keiji; Kito, Yosuke; Saito, Kei; Yamamoto, Shinzo; Takeuchi, Hiroya; Kudo, Toshihiro; Tsunoda, Takuya; Mizukami, Takuro; Yamaguchi, Toshifumi; Shoji, Hirokazu; Saito, Kanako; Tanoue, Kenro; Baba, Eishi; Nagashima, Kengo; Boku, Narikazu Share Save Clinical outcomes of recurrent or metastatic head and neck cancer after failure of platinum and nivolumab: a multicenter retrospective studyWatanabe, Takane; Oka, Hiroki; Nagashima, Kengo; Nishi, Hideaki; Kumai, Yoshihiko; Iijima, Hiroaki; Okami, Kenji; Shimizu, Yasushi; Kano, Satoshi; Ito, Kazue; Yamazaki, Tomoko; Oridate, Nobuhiko; Yokota, Tomoya; Koyama, Taiji; Kiyota, Naomi; Sato, Yasuyoshi; Takahashi, Shunji; Kato, Kyoko; Kadowaki, Shigenori; Honma, Yoshitaka Share Save Increased risk of proximal tubular dysfunction due to occupational cadmium exposure: a survival analysis studyHoshino, Kento; Iwasawa, Satoko; Yoshioka, Noriyuki; Suzuki, Satoko; Hashimoto, Itsumi; Ukita, Shoko; Toshima, Genta; Nagashima, Kengo; Takebayashi, Toru; Tsunoda, Masashi Share Save Ranibizumab with luseogliflozin in type 2 diabetes with diabetic macular oedema: A randomised clinical trialIshibashi, Ryoichi; Takatsuna, Yoko; Koshizaka, Masaya; Tatsumi, Tomoaki; Takahashi, Sho; Nagashima, Kengo; Ishikawa, Ko; Kaiho, Tomomi; Asaumi, Noriko; Baba, Takayuki; Yamamoto, Shuichi; Yokote, Koutaro; COMET Trial investigators Share Save Phase II trial of nab-paclitaxel plus ramucirumab in combination with nivolumab for unresectable advanced or recurrent gastric cancer after progression on first-line treatment including fluoropyrimidine, platinum, and anti-PD-1/PD-L1 antibody (PADDLE)Hirano, Hidekazu; Takahashi, Naoki; Amanuma, Yusuke; Suzuki, Nobumi; Takahari, Daisuke; Kawakami, Takeshi; Kudo-Saito, Chie; Nagashima, Kengo; Boku, Narikazu; Kato, Ken; Shoji, Hirokazu Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
